Loading organizations...
Loading organizations...
Develops human tissue-based products for vascular disease and surgery.
Humacyte has raised $301.1M across 5 funding rounds.
Humacyte has raised $301.1M in total across 5 funding rounds.
Humacyte has raised $301.1M in total across 5 funding rounds.
Humacyte's investors include Scott McCarty, California Institute for Regenerative Medicine, Brady Dougan, Gavril Yushvaev, Access Industries, Bangkok Bank, Pacific Eagle Asset Management, Reignwood Group.
Humacyte has raised $301.1M across 5 funding rounds. Most recently, it raised $50.0M Debt in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 14, 2021 | $50.0M Debt | Scott McCarty | |
| Mar 9, 2018 | $75.0M Series C | ||
| Sep 29, 2017 | $14.1M Grant | California Institute for Regenerative Medicine | |
| Oct 20, 2015 | $150.0M Series B | Brady Dougan, Gavril Yushvaev, Access Industries, Bangkok Bank, Pacific Eagle Asset Management, Reignwood Group | |
| Sep 8, 2010 | $12.0M Debt |